2016
DOI: 10.1017/s0033291716000350
|View full text |Cite
|
Sign up to set email alerts
|

Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis

Abstract: Attention-deficit/hyperactivity disorder (ADHD) in childhood and adulthood is often treated with the psychostimulant methylphenidate (MPH). However, it is unknown whether cognitive effects of MPH depend on age in individuals with ADHD, while animal studies have suggested age-related effects. In this meta-analysis, we first determined the effects of MPH on response inhibition, working memory and sustained attention, but our main goal was to examine whether these effects are moderated by age. A systematic litera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
45
0
2

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 61 publications
(49 citation statements)
references
References 103 publications
2
45
0
2
Order By: Relevance
“…These decision rules were based on the executive function research expertise of the third author and conform to recent literature specifications about quality of outcome measures of executive function (e.g. Tamminga, Reneman, Huizenga, & Geurts, 2016). The codes are described in Appendix D.…”
Section: Data Itemsmentioning
confidence: 99%
“…These decision rules were based on the executive function research expertise of the third author and conform to recent literature specifications about quality of outcome measures of executive function (e.g. Tamminga, Reneman, Huizenga, & Geurts, 2016). The codes are described in Appendix D.…”
Section: Data Itemsmentioning
confidence: 99%
“…Systematic reviews of the literature show that performance on task-based measures of these domains are improved by stimulants, but to a modest extent only. Tamminga and colleagues conducted a systematic review of MPH effects across the lifespan on these domains of executive functioning (Tamminga, Reneman, Huizenga, & Geurts, 2016). Across 50 studies (1,611 participants mean-aged 4.8 to 50.1), small-to-moderate effects of MPH were found.…”
Section: Effects Of Stimulants On Cognitive Processesmentioning
confidence: 99%
“…Currently, medication is the first-line treatment recommended to improve cognitive functioning, including WM, and ADHD symptoms. Both stimulants (amphetamines and methylphenidate) and nonstimulants (atomoxetine, clonidine, and guanfacine) are used for the purpose (Fredriksen, Halmøy, Faraone, & Haavik, 2013;Strand et al, 2012;Tamminga, Reneman, Huizenga, & Geurts, 2016).…”
mentioning
confidence: 99%